Target intelligence / Profile preview

Cytoplasmic tRNA 2-thiolation protein 2 (CTU2)

Target
CTU2
Molecular classification
Enzyme (specifically, tRNA-modifying enzyme), Other (tRNA thiolase complex component)
01

Overview

Cytoplasmic tRNA 2-thiolation protein 2 (CTU2) is a highly conserved protein that forms a complex with CTU1 (known as Ctu1–Ctu2 or cytosolic thiouridylase) responsible for the 2-thiolation of uridine at the wobble position (U34) of several cytosolic tRNAs, specifically those for lysine, glutamine, and glutamate[1][2][3][4]. This modification, mcm^5^S^2^U, is crucial for maintaining the fidelity and efficiency of translation by restricting aberrant base pairing and reducing frameshifting—ultimately supporting accurate decoding of mRNA by the ribosome[1][2][3]. Loss of function or inactivation of the CTU1–CTU2 complex leads to unthiolated tRNAs, associated with genome instability, defective cell growth, and impaired viability under stress, but there is no direct implication as a receptor, transporter, or canonical therapeutic target[1][3][4]. CTU2 does not have known direct disease associations, approved drugs, or biomarker use cases, but it is essential for the proper translation machinery and genomic integrity in eukaryotic cells[1][2][4].

Other names
C16orf84NCS2MFRGUPF0432Cytosolic thiouridylase subunit 2Cytoplasmic tRNA 2-thiolation protein 2 homologcytosolic thiouridylase subunit 2 homologNCS2/Tuc2 (in yeast)
02

Biological functions

Post-transcriptional tRNA modification2-thiolation of wobble uridine in tRNAsMaintenance of translation fidelity and efficiencyGenome stability maintenance
03

Disease associations

Other (genome instability, but no direct implication in major disease classes like cancer, neurodegeneration, etc., in the literature reviewed)

Beyond the preview

Go deeper on Cytoplasmic tRNA 2-thiolation protein 2 (CTU2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytoplasmic tRNA 2-thiolation protein 2 (CTU2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call